Vice President, New Product Planning
Carolyn Hobbs joined AnaptysBio in January 2018 with more than 20 years of experience in marketing, commercialization, and new product planning of novel therapeutic products. Carolyn previously led new product planning at Sanofi and established commercialization strategies for key biologic products, including Dupixent®, Kevzara®, Praluent® and Toujeo®. Previously, Carolyn had marketing leadership responsibility for Sanofi-Genzyme’s multiple sclerosis franchise products, including Aubagio® and Lemtrada®. Carolyn received her B.A. at Princeton University and her M.B.A. from the Richard Ivey School of Business at the University of Western Ontario.